PP01.45: Evaluating the Clinical Utility of Combined Biomarkers in Predicting Immunotherapy Response in Advanced NSCLC: An Evidence-Based Medicine Approach

Journal of Thoracic Oncology 2026

View at publisher

Authors: Wan Ling Chiu

DOI: 10.1016/j.jtho.2025.12.049

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Lung Cancer Research Studies